-
Neothetics Inc (NASDAQ: NEOT) shares dropped 69.6
percent to $0.709. Neothetics disclosed that LIPO-202 did not show any improvement on efficacy measurements.
-
Matinas BioPharma Holdings Inc (NYSE: MTNB) shares
declined 18.1 percent to $2.27. Matinas BioPharma reported that Phase 2 clinical study of orally-administered MAT2203 for the
treatment of vulvovaginal candidiasis did not meet expectations.
-
Gener8 Maritime Inc (NYSE: GNRT) shares tumbled
14.1 percent to $5.26.
-
Internet Gold Golden Lines Ltd (NASDAQ: IGLD)
shares declined 13.1 percent to $9.79.
-
Seattle Genetics, Inc. (NASDAQ: SGEN) shares
dropped 11.2 percent to $54.81. Seattle Genetics disclosed that Phase 3 ECHELON-1 trial met its primary endpoint.
-
Stratasys, Ltd. (NASDAQ: SSYS) shares dipped 11
percent to $24.56. Goldman Sachs downgraded Stratasys from Neutral to Sell.
-
Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX)
shares declined 11 percent to $9.31.
-
HealthStream, Inc. (NASDAQ: HSTM) dropped 10
percent to $27.79. HealthStream repoted that Laerdal Medical A/S has ended renewal negotiations for the agreements with
HealthStream.
-
Agios Pharmaceuticals Inc (NASDAQ: AGIO) shares
fell 9.7 percent to $53.43. Agios Pharma disclosed updated data from fully enrolled DRIVE PK study demonstrating AG-348's
potential as first disease-modifying treatment for patients with PKR at the European Hematology Association. Janney Capital
downgraded Agios Pharmaceuticals from Buy to Neutral.
-
DryShips Inc. (NASDAQ: DRYS) shares dropped 6.6
percent to $2.28 after tumbling 13.78 percent on Friday.
-
Arconic Inc (NYSE: ARNC) shares declined 6.1
percent to $23.98 as the company said in emails it knowingly supplied flammable panels for use in Grenfell Tower.
-
GrubHub Inc (NYSE: GRUB) dropped 6.5 percent to
$44.60. Morgan Stanley downgraded GrubHub from Overweight to Equal-Weight.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.